Distal symmetric polyneuropathy presents a significant diagnostic challenge for clinicians due to its vague, progressive symptomology and complex differential. Dr. Ario Mirian, a neurology resident, clarifies that while common causes like diabetes are frequent, clinicians must remain vigilant for red flags—such as rapid progression under eight weeks, asymmetry, or systemic symptoms—that necessitate urgent investigation. High-yield diagnostic tests include CBC, vitamin B12 levels, and serum protein electrophoresis. Management focuses on symptomatic relief rather than complete remission, utilizing gabapentinoids, SNRIs, or tricyclic antidepressants to improve quality of life. Beyond pharmacological interventions, identifying reversible factors like vitamin B6 toxicity or alcohol use is essential. While nerve conduction studies provide diagnostic confirmation, they are not always required for every patient, and referral to a specialist is best reserved for cases involving red flags or significant, progressive disability.
Sign in to continue reading, translating and more.
Open full episode in Podwise
